Correlation Between Tscan Therapeutics and 172967KM2
Specify exactly 2 symbols:
By analyzing existing cross correlation between Tscan Therapeutics and C 625, you can compare the effects of market volatilities on Tscan Therapeutics and 172967KM2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of 172967KM2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and 172967KM2.
Diversification Opportunities for Tscan Therapeutics and 172967KM2
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tscan and 172967KM2 is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and C 625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 172967KM2 and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with 172967KM2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 172967KM2 has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and 172967KM2 go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and 172967KM2
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 5.95 times more return on investment than 172967KM2. However, Tscan Therapeutics is 5.95 times more volatile than C 625. It trades about 0.05 of its potential returns per unit of risk. C 625 is currently generating about 0.02 per unit of risk. If you would invest 336.00 in Tscan Therapeutics on September 4, 2024 and sell it today you would earn a total of 149.00 from holding Tscan Therapeutics or generate 44.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 98.97% |
| Values | Daily Returns |
Tscan Therapeutics vs. C 625
Performance |
| Timeline |
| Tscan Therapeutics |
| 172967KM2 |
Tscan Therapeutics and 172967KM2 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and 172967KM2
The main advantage of trading using opposite Tscan Therapeutics and 172967KM2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, 172967KM2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 172967KM2 will offset losses from the drop in 172967KM2's long position.| Tscan Therapeutics vs. Candel Therapeutics | Tscan Therapeutics vs. Cingulate Warrants | Tscan Therapeutics vs. Unicycive Therapeutics | Tscan Therapeutics vs. Cardio Diagnostics Holdings |
| 172967KM2 vs. AEP TEX INC | 172967KM2 vs. US BANK NATIONAL | 172967KM2 vs. MetLife | 172967KM2 vs. Brera Holdings PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |